Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Launched by KIDSIM SIMULATION PROGRAM · May 11, 2023
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a special device called an aerosol box during emergency procedures like CPR, particularly for patients who have cardiac arrest and may be infected with COVID-19. The aerosol box is designed to protect healthcare workers from tiny virus particles that can spread in the air while they are performing life-saving techniques. The research aims to understand how these particles move during CPR and how effective the aerosol box is in keeping healthcare workers safe from infection.
To participate in this study, individuals must be qualified healthcare providers such as doctors, nurses, or respiratory therapists who have the necessary training in advanced life support. Participants will be involved in testing the aerosol box to see how it helps during critical moments when patients need immediate care. This research is important because it could lead to safer practices in hospitals, protecting both patients and healthcare workers during emergencies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Airway Provider:
- • Attending physician, fellow or resident in adult or pediatric emergency medicine, pediatric intensive care, general pediatrics or pediatric/adult anesthesia
- • Adult or Pediatric Advanced Life Support certification.
- CPR Provider:
- • Attending physician, resident, fellow, nurse, respiratory therapist, physician assistant or health care aide
- • Basic Life Support, Adult or Pediatric Advanced Life Support certification
- Exclusion Criteria:
- • Decline to provide informed consent
- • Unable to perform tasks required of the role due to physical limitations.
About Kidsim Simulation Program
The Kidsim Simulation Program is a pioneering clinical trial sponsor dedicated to advancing pediatric healthcare through innovative simulation-based training and research. By employing cutting-edge simulation technologies, Kidsim enhances the clinical skills and decision-making abilities of healthcare professionals caring for children. The program focuses on developing evidence-based practices and improving patient outcomes by conducting rigorous clinical trials that assess the effectiveness of various simulation methodologies in pediatric settings. Through collaboration with medical institutions and experts, Kidsim aims to foster a safer and more effective healthcare environment for children.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Los Angeles, California, United States
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Patients applied
Trial Officials
Adam C Cheng, MD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported